Indonesia to Regulate Kratom: Ensuring Quality and Expanding Export Markets

Indonesia announced plans to regulate the cultivation and export of kratom, a substance known for easing pain but classified as a drug of concern in the U.S. The regulation aims to improve quality and expand market reach, with President Joko Widodo directing national research on its usage and dosage.

Indonesia said on Thursday it would start regulating the cultivation and export of kratom, a substance that advocates say can help ease pain alongside other benefits, but is listed in the U.S. as a drug of concern. The controls on the native Southeast Asian tree leaves would improve quality, the president's chief of staff, Moeldoko, told reporters. "A number of our exporters faced rejections because their products had been contaminated," he said.

People in the Indonesian part of Borneo island have been growing and consuming kratom for generations, using it as a traditional treatment for a range ailments. The leaves, which are also grown, sold and exported across the region, have been used in products that promise to ease pain, anxiety and depression and to help people cope with opioid use disorder and opioid withdrawal.

But the U.S. Food and Drug Administration (FDA) has said kratom has similar effects to narcotics such as opioids, has listed it as a "drug and chemical of concern" and has not approved it for any medical use. Indonesia's President Joko Widodo has instructed the national research agency BRIN to look into the consumption of kratom, especially its dosage, Moeldoko said.

Under the planned new regulations, the government would also limit the number of companies allowed to export kratom in a bid to keep up standards, he added. Asked about prohibition of kratom use in a number of countries, Moeldoko said at least 20 markets were interested in importing Indonesian kratom.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)